A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.

Why are some filings missing?

New filings appear as the SEC updates EDGAR, and older records can vary by availability.

How often is this page updated?

Updates follow new EDGAR submissions and periodic data refreshes.

SEC EDGAR filings, ownership reports, and insider transactions for John Vavricka.

Business address: C/O Atea Pharmaceuticals, Inc., 225 Franklin Street Suite 2100, Boston, MA
Top holdings (ownership): AVIR

Get insider transactions for this reporting owner

John Vavricka has filed 9 SEC EDGAR filings since 29 Oct 2020

Recent SEC filings for John Vavricka including 4, 144, 3.

Form type	Document	Filing	Description	Filing date	Reporting date	File number(s)
4	Open 4 document	View SEC filing for 4	4	03 Feb 2026	31 Jan 2026	001-39661
4	Open 4 document	View SEC filing for 4	4	04 Feb 2025	31 Jan 2025	001-39661
4	Open 4 document	View SEC filing for 4	4	02 Feb 2024	31 Jan 2024	001-39661
144	Open 144 document	View SEC filing for 144		01 Feb 2024
4	Open 4 document	View SEC filing for 4	FORM 4 SUBMISSION	02 Feb 2023	31 Jan 2023	001-39661
4	Open 4 document	View SEC filing for 4	FORM 4 SUBMISSION	02 Feb 2022	31 Jan 2022	001-39661
4	Open 4 document	View SEC filing for 4	FORM 4 SUBMISSION	01 Feb 2021	29 Jan 2021	001-39661
4	Open 4 document	View SEC filing for 4	FORM 4 SUBMISSION	03 Nov 2020	03 Nov 2020	001-39661
3	Open 3 document	View SEC filing for 3	FORM 3 SUBMISSION	29 Oct 2020	29 Oct 2020	001-39661

John Vavricka files with the SEC under CIK 0001829630. This page aggregates EDGAR filings and related ownership activity.

What is a CIK?: A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?: New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?: Updates follow new EDGAR submissions and periodic data refreshes.